PR

Prashant Ramesh Deshmukh

Active Director Director DIN 08264260
DIN 08264260 First appointment Oct 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Prashant Ramesh Deshmukh

Data last updated:

Prashant Ramesh Deshmukh is a Director at Mediroot Pharma Private Limited (since 2018). The company operates in Business Services.

DIN 08264260
Primary Designation Director
Industry Business Services
First Appointment 24 Oct 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mediroot Pharma Private Limited U74999MH2018PTC316199
Director24 Oct 20182018Active

Board colleagues of Prashant Ramesh Deshmukh

NameDINCompanyDesignation
Atul Bhaskarrao Karde06466263Mediroot Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mediroot Pharma Private Limited
Premium access

Shareholding and investment profile for Prashant Ramesh Deshmukh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prashant Ramesh Deshmukh

Prashant Ramesh Deshmukh currently holds 1 directorship: Mediroot Pharma Private Limited (Director, since 24 Oct 2018).

Prashant Ramesh Deshmukh was first appointed on 24 Oct 2018 as Director at Mediroot Pharma Private Limited.

The current boards of Prashant Ramesh Deshmukh's companies include Atul Bhaskarrao Karde (Mediroot Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available